{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:59:33Z","timestamp":1775476773880,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>A short-term weight reduction program for potential living donors was introduced to reduce the extent of hepatic steatosis prior to liver transplantation. We aimed to investigate changes in non-invasive hepatic steatosis and fibrosis indices among those who completed the program.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Among 1,950 potential living liver donors between January 2011 and May 2019, 160 living donors joined the weight reduction program. The prospectively collected clinical data of these potential liver donors were analyzed retrospectively. Hepatic steatosis and fibrosis scores were determined using the fatty liver index (FLI), hepatic steatosis index (HSI), and NAFLD fibrosis score (NFS) and compared to MR spectroscopy (MRS) fat fraction results before and after weight reduction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty-nine potential living donors who had undergone MRS both before and after weight reduction were included in the analysis. Their body weight decreased from 78.02 \u00b1 10.89 kg to 72.36 \u00b1 10.38 kg over a mean of 71.74 \u00b1 58.11 days. FLI, HSI, and MRS values decreased significantly from 41.52 \u00b1 19.05 to 24.53 \u00b1 15.93, 39.64 \u00b1 3.74 to 35.06 \u00b1 3.82, and 12.20 \u00b1 4.05 to 6.24 \u00b1 3.36, respectively. No significant decreases in NFS were observed. There was a significant correlation between the extent of HSI change and the extent of MRS change (R<jats:sup>2<\/jats:sup> value = 0.69, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), although there was no correlation between MRS and FLI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The weight reduction program significantly improved non-invasive indices of hepatic steatosis over a short period. HSI may allow for prediction of simple decreases in hepatic steatosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2022.827526","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T05:20:47Z","timestamp":1651555247000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction"],"prefix":"10.3389","volume":"9","author":[{"given":"Jaehyuk","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YoungRok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su young","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanggyun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangpyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui Soo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk Kyun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Joon","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Woong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Suk","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jhep.2011.03.020","article-title":"Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort","volume":"56","author":"Armstrong","year":"2012","journal-title":"J Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jhep.2007.02.007","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center","volume":"47","author":"Lee","year":"2007","journal-title":"J Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","article-title":"NAFLD in Asia\u2013as common and important as in the West","volume":"10","author":"Farrell","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3350\/cmh.2013.19.3.266","article-title":"Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea","volume":"19","author":"Jeong","year":"2013","journal-title":"Clin Mol Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s11605-015-2832-1","article-title":"Donor hepatic steatosis and outcome after liver transplantation: a systematic review","volume":"19","author":"Chu","year":"2015","journal-title":"J Gastrointest Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3962785","DOI":"10.1155\/2019\/3962785","article-title":"The impact of steatosis on the outcome of liver transplantation: a meta-analysis","volume":"2019","author":"Zhang","year":"2019","journal-title":"Biomed Res Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/lt.24762","article-title":"Evaluation of donor workups and exclusions in a single-center experience of living donor liver transplantation","volume":"23","author":"Nugroho","year":"2017","journal-title":"Liver Transpl."},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1097\/01.sla.0000179652.07502.3f","article-title":"Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome","volume-title":"Ann Surg.","author":"Mattar","year":"2005"},{"key":"B11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/01.tp.0000166009.77444.f3","article-title":"Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation","volume":"80","author":"Nakamuta","year":"2005","journal-title":"Transplantation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1440-1746.2012.07165.x","article-title":"Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors","volume":"27","author":"Jin","year":"2012","journal-title":"J Gastroenterol Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/lt.20172","article-title":"The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation","volume":"10","author":"Hwang","year":"2004","journal-title":"Liver Transpl."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/lt.24495","article-title":"Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation","volume":"22","author":"Doyle","year":"2016","journal-title":"Liver Transpl."},{"key":"B17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","article-title":"The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis","volume":"21","author":"Bohte","year":"2011","journal-title":"Eur Radiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00261-012-9930-2","article-title":"(1)H MRS assessment of hepatic steatosis in overweight children and adolescents: comparison between 3T and open 1T MR-systems.","volume":"38","author":"Chabanova","year":"2013","journal-title":"Abdom Imaging."},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4174\/astr.2015.89.1.37","article-title":"Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging","volume":"89","author":"Choi","year":"2015","journal-title":"Ann Surg Treat Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1148\/radiol.14130863","article-title":"Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy","volume":"271","author":"Hwang","year":"2014","journal-title":"Radiology."},{"key":"B21","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume-title":"Gastroenterology.","author":"Castera","year":"2019"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.transproceed.2019.01.177","article-title":"The utility of noninvasive scoring systems for prediction of hepatic steatosis in liver transplantation donor candidates","volume":"51","author":"Sahin","year":"2019","journal-title":"Transplant Proc."},{"key":"B23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","article-title":"External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study","volume":"11","author":"Koehler","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/DMSO.S189544","article-title":"The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011","volume":"12","author":"Khang","year":"2019","journal-title":"Diabetes Metab Syndr Obes."},{"key":"B26","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/jgh.13814","article-title":"Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes","volume":"33","author":"Sviklane","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3748\/wjg.v19.i8.1219","article-title":"NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients","volume":"19","author":"Treeprasertsuk","year":"2013","journal-title":"World J Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jgh.13648","article-title":"External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients","volume":"32","author":"Jun","year":"2017","journal-title":"J Gastroenterol Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1148\/radiol.2213010106","article-title":"Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings","volume":"221","author":"Cho","year":"2001","journal-title":"Radiology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jhep.2008.10.016","article-title":"Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?","volume":"50","author":"Bonekamp","year":"2009","journal-title":"J Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e94059","DOI":"10.1371\/journal.pone.0094059","article-title":"Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance","volume":"9","author":"Kahl","year":"2014","journal-title":"PLoS One."},{"key":"B34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/EJE-14-0112","article-title":"External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals","volume":"171","author":"Cuthbertson","year":"2014","journal-title":"Eur J Endocrinol."},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.15799","article-title":"Validation of five hepatic steatosis algorithms in metabolic- associated fatty liver disease: a population based study","volume-title":"J Gastroenterol Hepatol.","author":"Liu","year":"2022"},{"key":"B36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/ctr.12343","article-title":"Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation","volume":"28","author":"Kim","year":"2014","journal-title":"Clin Transplant."}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.827526\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T05:20:52Z","timestamp":1651555252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.827526\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":36,"alternative-id":["10.3389\/fsurg.2022.827526"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2022.827526","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"article-number":"827526"}}